Radiocontrast-induced nephropathy and percutaneous coronary intervention: a review of preventive measures

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.5, 2003-05, pp. : 639-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D. Keating Gillian M. Wellington Keri

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite

N-Acetylcysteine and Other Preventive Measures for Contrast-Induced Nephropathy in the Intensive Care Unit

Current Medicinal Chemistry, Vol. 13, Iss. 21, 2006-09 ,pp. : 2565-2570

Bentham Science Publishers

Access to resources Recommend Favorite

Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes

By Plosker G.L. Ibbotson T.

PharmacoEconomics, Vol. 21, Iss. 12, 2003-01 ,pp. : 885-912

Adis International

Access to resources Recommend Favorite

Eptifibatide: A Review of its Use in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

By Curran Monique P. Keating Gillian M.

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 2009-2035

Adis International

Access to resources Recommend Favorite

Prasugrel: A Review of its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

By Duggan Sean T. Keating Gillian M.

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1707-1726

Adis International

Access to resources Recommend Favorite